> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# IC-Green Not Withdrawn Due to Safety/Efficacy
- URL: https://www.fdaweb.com/ic-green-not-withdrawn-due-to-safety-efficacy/
- Published: 2024-11-21T12:00:00.000Z
- Updated: 2026-09-14T14:47:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5158237

*Federal Register* notice: FDA has determined that Renew Pharmaceuticals’ IC-Green (indocyanine green) was not withdrawn from sale for reasons of safety or effectiveness. The determination will allow the agency to approve ANDAs that reference the product if all other legal and regulatory requirements are met. IC-Green is indicated for determining cardiac output, hepatic function, and liver blood flow. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-11-20/pdf/2024-27090.pdf?ref=fdaweb.com).